Clinical Trial Update: Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is comparing low-dose exemestane with low-dose tamoxifen in post-menopausal women at high risk for breast cancer and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Exemestane (Exemestane)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Andrea DeCensi | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING